Global Blockchain Market in Healthcare (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts

Dublin, Feb. 04, 2021 (GLOBE NEWSWIRE) -- The "Blockchain Market in Healthcare - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

The blockchain market in healthcare was valued at USD 2.12 billion in 2020, and is expected to reach USD 3.49 billion by 2026, with a CAGR of 8.7% during the forecast period, 2021 - 2026. In 2018, the Illinois Blockchain Initiative (IBI) launched several pilots, including a birth registration pilot to develop secure identity solutions and a pilot to develop blockchain health provider credentialing solutions. Proposals like these are expected to improve the market conditions.

In 2018, the healthcare industry continued to be plagued by data breaches involving sensitive patient information, with public reports of hacking and phishing incidents, reminding how vulnerable the patient data remains. According to the Breach Barometer 2019 Report, more than 15 million patients' records were breached in 2018. Such incidents allow blockchain vendors to launch new solutions.

Government mandates require healthcare industries to come up with innovative ways to manage their assets. From February 2019, the Falsified Medicines Directive (FMD) came into force across the European Union. This prescription medicines came with a security feature enabling the hospitals, pharmacies, or healthcare providers to verify their authenticity.

One of the biggest challenges faced by the healthcare industry is lack of understanding and awareness of a trustless system. Most of the application of blockchain are in the BFSI sector. Additionally, the bad reputation of bitcoin, highlighted by media, discourages the market expansion.

Key Market Trends

Managing Healthcare Supply Chain Using Blockchain to Dominate the Market

• The WHO estimates that many countries in Africa and parts of Asia and Latin America have areas where more than 30% of the medicines on sale can be counterfeit.

• Pharmaceutical supply chain surveillance has shown that incidents of substandard or counterfeit medicines continue to increase, which are perceived to be legitimate supply chains around the world. Several factors have contributed to these incidents, such as pharmaceutical supply chains, which are very complex and are at risk due to the involvement of under-regulated wholesalers, illicit distributors, non-legitimate internet pharmacies, and multiple routes for importation around the world.

• Advancements in technology have made it easier for pharmaceutical counterfeiting, to copy both product packaging and the pharmaceutical itself, so that there is a little distinction.

• When a recall happens, manufacturers must communicate clearly and swiftly with the entire supply chain, from wholesale to retail pharmacies, and collect the faulty item. This demands an increased need of collaboration which can be attained by Blockchain.

North America to Witness the Highest Growth

• In the United States, the FDA's Drug Supply Chain Security Act outlines requirement to develop and enhance the drug supply chain security by 2023. These developments are good news for the blockchain industry, as the companies try to manage product quality and security.

• Major US healthcare companies have formed an alliance called Synaptic Health Alliance, which consists Humana, Multiplan, UnitedHealth Group's Optum, UnitedHealthcare, and Quest Diagnostics and Ascension to try blockchain solutions, in order to improve data quality and reduce costs.

• According to the Centers for Medicare & Medicaid Services, at least half of the information on the Medicare Advantage Organizations had errors, which affects the customers by causing delay in medical services and can make them subject to fines.

• In Boston, medical offices use more than two dozen systems for maintaining electronic health records. This makes them prone to fraud and hacking.

• Ageing population and rising healthcare costs indicate higher healthcare spending in the United States. Thus, blockchain offers a potential solution to safeguard patient and clinical data.

Competitive Landscape

The market for blockchain is limited due to expertise required in implementing any of the new projects, thus, creating a high entry barrier. The concentrated market allows enterprises to take advantage of specialized blockchain healthcare offerings from vendors, like Gem, IBM, and Microsoft.

• May 2019 - Batam (Indonesia) planned to bring together a significant number of partners, to help deliver a blockchain solution for its citizens. The primary partnership is between BP Batam, through BP Batam Hospital, and dClinic, who have engaged Deloitte Southeast Asia and JP Consulting, to provide project management and clinical governance expertise.

• Jan 2019 - Aetna, Anthem, Health Care Service Corporation (HCSC), PNC Bank, and IBM announced a new collaboration, to design and create a network using blockchain technology and to improve transparency and interoperability in the healthcare industry. The aim is to create an inclusive blockchain network that can benefit multiple members of the healthcare ecosystem in a highly secure and shared environment.

Reasons to Purchase this report:

• The market estimate (ME) sheet in Excel format

• 3 months of analyst support

Key Topics Covered:

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increasing Data Breaches in Healthcare Industry is Driving the Market Growth
4.3.2 Government Mandates Regarding Maintaining Medicine Quality is Increasing the Market Demand
4.4 Market Restraints
4.4.1 Lack of Awareness Regarding Blockchain Functionality is Hindering the Market Growth
4.5 Industry Value Chain Analysis
4.6 Industry Attractiveness - Porter's Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Clinical Data Exchange
5.1.2 Billing Management and Claims Adjudication
5.1.3 Supply Chain Management
5.2 By Geography
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 Latin America
5.2.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 IBM Corporation
6.1.2 Microsoft Corporation
6.1.3 Gem
6.1.4 Patientory Inc.
6.1.5 Guardtime Federal
6.1.6 Hashed Health
6.1.7 Factom Inc.
6.1.8 iSolve LLC
6.1.9 PokitDok Inc.
6.1.10 Chronicled Inc.

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/fq08s5

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900